Provided by Tiger Trade Technology Pte. Ltd.

DOGWOOD THERAPEUTICS INC

2.49
+0.16006.87%
Post-market: 2.490.00000.00%19:30 EDT
Volume:123.60K
Turnover:301.16K
Market Cap:84.64M
PE:-1.45
High:2.58
Open:2.31
Low:2.31
Close:2.33
52wk High:9.50
52wk Low:1.28
Shares:33.99M
Float Shares:5.81M
Volume Ratio:1.80
T/O Rate:2.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7149
EPS(LYR):-7.1350
ROE:-47.77%
ROA:-20.83%
PB:1.24
PE(LYR):-0.35

Loading ...

Company Profile

Company Name:
DOGWOOD THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
- -
Office Location:
44 Milton Avenue,Alpharetta,Georgia,United States
Zip Code:
30009
Fax:
- -
Introduction:
Dogwood Therapeutics, Inc. was originally incorporated in Alabama in February 2012 and later reincorporated in Nevada. It is a pre-revenue, development-stage biopharmaceutical company focused on discovering and developing novel treatments for pain and neuropathy. Its pipeline centers on chronic neuropathic pain, with the core product being the Halneuron Nav1.7 modulator program—a proprietary non-opioid analgesic approach that targets the voltage-gated sodium channel Nav1.7 to alleviate pain.

Directors

Name
Position
Greg Duncan
Chairman of the Board and Chief Executive Officer and Director
Abel De La Rosa
Director
Alan Yu
Director
David Keefer
Director
John C. Thomas, Jr.
Director
Melvin Toh
Director
Richard J. Whitley
Director

Shareholders

Name
Position
Greg Duncan
Chairman of the Board and Chief Executive Officer and Director
Angela Walsh
Chief Financial Officer and Corporate Secretary and Treasurer
Ralph Grosswald
Senior Vice President of Operations
R. Michael Gendreau
Chief Medical Officer